COVID-19 Resources
See how COVID-19 affects kidney health, receive guidance on how to clean our products and our response to the pandemic.
Why ACIST?
ACIST Medical Systems provides diagnostic technologies that deliver the power to visualize, assess and improve patient treatment.
Your cath lab knowledge catalyst
Reducing contrast volume
For interventional cardiologists who want to manage contrast delivery and minimize risk of contrast-induced acute kidney injury (CI-AKI), ACIST CVi™ delivers the power to control and protect.
Optimizing interventions
ACIST HDi® provides you the power to see with clarity, for optimizing PCI through intravascular imaging.
Complexity, simplified
ACIST RXi® and ACIST RXi® Mini™ simplify physiological assessment of complex coronary artery disease. The Navvus®
MicroCatheters give you the freedom to quickly and easily assess FFR.
Ultra-Low Contrast Imaging and PCI with ACIST Technology
Minimizing the contrast exposure and possibly using the least nephrotoxic contrast are critical in angiography and percutaneous coronary intervention (PCI) in patients with pre-existing chronic kidney disease (CKD).
By Ziad A. Ali, MD, DPhil
30+ million
Cases performed with CVi
3 views
Experience three imaging modes with HDi
0.014" guidewire
Use your guidewire of choice with RXi and the Navvus® MicroCatheters.
Investing in clinician education
ACIST provides a variety of clinical education materials, including clinical research, continuing education webinars, videos, instructional materials and more.
Thinking ahead with our physician training
Citations
- Westra J, Andersen BK et al; Diagnostic performance of in-procedure angiography-derive Quantitative Flow Reserve compared to pressure-derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study J Am Heart Assoc 2018
- Data on file. TR-11392R. Based on an amplitude increase of 1.56mmHg and a significant p-value of 0.01 as compared to AT P65.
